Cebix Obtains $8,799,305 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ff88958d-8348-40d4-995a-2bb5d05578a3&Preview=1
Date
3/9/2012
Company Name
Cebix
Mailing Address
1298 Prospect Street La Jolla, CA 92037
Company Description
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.
Website
http://www.cebix.com
Transaction Type
Debt
Transaction Amount
$8,799,305
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed